Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Holding EDIT?
Track your performance easily

Editas Medicine (EDIT) Financial Statements

3,248 Followers

Editas Medicine Financial Overview

Editas Medicine's market cap is currently ―. The company's EPS TTM is $-2.359; its P/E ratio is -1.23; Editas Medicine is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 513.00K$ 1.14M$ 60.05M$ 5.34M$ 2.89M
Gross Profit$ 513.00K$ 1.14M$ 60.05M$ 5.34M$ 2.89M
EBIT$ -67.61M$ -66.99M$ -23.96M$ -45.02M$ -40.29M
EBITDA$ -64.47M$ -65.58M$ -22.50M$ -46.23M$ -38.75M
Net Income Common Stockholders$ -67.61M$ -61.95M$ -18.87M$ -45.02M$ -40.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 279.11M$ 296.17M$ 323.11M$ 349.62M$ 431.97M
Total Assets$ 384.80M$ 440.34M$ 499.15M$ 504.65M$ 541.95M
Total Debt$ 38.70M$ 34.14M$ 36.54M$ 34.61M$ 37.19M
Net Debt$ -240.41M$ -262.03M$ -286.57M$ -315.01M$ -394.78M
Total Liabilities$ 152.79M$ 145.95M$ 150.06M$ 144.19M$ 142.04M
Stockholders Equity$ 192.92M$ 287.70M$ 349.10M$ 360.46M$ 399.92M
Cash Flow-
Free Cash Flow$ -60.56M$ -51.74M$ -23.55M$ -35.70M$ -40.04M
Operating Cash Flow$ -57.06M$ -49.87M$ -22.24M$ -35.46M$ -38.71M
Investing Cash Flow$ 51.95M$ -4.75M$ 62.84M$ -102.82M$ 12.98M
Financing Cash Flow$ 322.00K$ 192.00K$ 514.00K-$ 117.53M
Currency in USD

Editas Medicine Earnings and Revenue History

Editas Medicine Debt to Assets

Editas Medicine Cash Flow

Editas Medicine Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis